Ask Fiona AI
AI assistant for cancer patients navigating clinical trials
Company profile
Company profile
Massive Bio is a precision oncology company that leverages artificial intelligence to revolutionize cancer clinical trial access and patient recruitment. The company's Synergy AI Platform connects cancer patients with clinical trials regardless of their location or financial circumstances, bringing together physicians, drug developers, hospitals, and genomic companies in a comprehensive ecosystem. The platform analyzes over 500 medical data elements from patient records to match individuals with suitable trials from a database of 19,000+ active interventional cancer clinical trials worldwide. Massive Bio serves multiple stakeholders through specialized solutions: Patient Connect empowers patients and caregivers to navigate their clinical trial journey, Trial Relay enables physicians to seamlessly refer patients for trial matching, Reticulum Nexus supports clinical operations teams with AI-enabled multi-trial matching, and Trial Vision provides pharma and CRO clients with real-time recruitment analytics. The company has onboarded over 200,000 cancer patients and operates across 45+ markets globally, partnering with patient advocacy organizations, pharmaceutical companies, and healthcare institutions. Massive Bio combines AI technology with human expertise from oncology nurses and physicians to deliver personalized trial matching reports within 24 hours, while maintaining strict compliance with HIPAA, GDPR, PIPEDA, SOC 2 Type II, and PCI-DSS standards.
Company description Massive Bio official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
Launched Nexus Pulse AI-native market intelligence platform for biopharma commercial teams; created 'Little Tales for Massive Heroes' therapeutic storybook for pediatric cancer support; attending ASCO 2026
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI assistant for cancer patients navigating clinical trials
AI co-pilot for physicians to summarize patient disease and find matching trials
Comprehensive AI platform powering precision oncology solutions
AI-native market intelligence platform for biopharma commercial teams
Patient portal for navigating clinical trial journey anytime, anywhere
AI-enabled multi-trial matching system for clinical operations teams
AI-powered clinical trial matching and referral system for physicians
Real-time analytics for tracking patient recruitment and referral activity
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · Jun 1, 2026
Transforming oncology clinical trial matching through neuro-symbolic, multi-agent AI and an oncology-specific knowledge graph: a prospective evaluation in 3804 patients.ESMO real world data and digital oncology · Jun 1, 2026
Defining a Multi-Omic, AI-Enabled Stool Screening Paradigm for Colorectal Cancer: A Consensus Framework for Clinical Translation.Cancers · Mar 11, 2026
A unified framework for pre-screening and screening tools in oncology clinical trials.NPJ precision oncology · Jan 30, 2026
Empowering Global Hematology-Oncology Education: Assessing the Impact of a Virtual Platform in Combating Educational Inequity.JCO global oncology · Nov 1, 2025
RadOncRAG: A Novel Retrieval-Augmented Generation Framework Improves Large Language Model Benchmark Performance in Radiation Oncology.JCO clinical cancer informatics · Nov 1, 2025
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Total patients using the platform
Clinical trials available for matching
Time to receive personalized trial matching report
Clinical parameters extracted and analyzed
Geographic reach
U.S. Army veteran with stage 4 lung cancer matched to clinical trials through AI-driven platform
Patient found promising results through clinical trials with comprehensive support
Myelofibrosis patient from Spain matched to clinical trials through AI-guided platform
Patient found suitable clinical trial and saw positive results with support described as 'humane and wonderful'
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Massive Bio's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.